Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. (Q54485562)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. |
scientific article |
Statements
Clinical phase I study of elpamotide, a peptide vaccine for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. (English)
1 reference
Isamu Okamoto
1 reference
Tokuzo Arao
1 reference
Masaki Miyazaki
1 reference
Taroh Satoh
1 reference
Kunio Okamoto
1 reference
Takuya Tsunoda
1 reference
Kazuto Nishio
1 reference
Kazuhiko Nakagawa
1 reference
14 October 2012
1 reference
103
1 reference
2135-2138
1 reference
12
1 reference
1 reference
1 reference
1 reference
1 reference
2 references
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference